3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles
Selected Variant
HY-142042-01
Size: 5 mg
3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles is an inhibitor for bone morphogenetic protein 2 (BMP2) with an IC50 of 2.2 μM. 3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles is inhibitor for mitogen-activated protein kinase 1 (MEK1) . 3-Hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles exhibits anti-inflammatory and neuroprotective activity in EAE mouse model[1][2].
Product Specifications
CAS Number
287196-91-2
UNSPSC
12352005
Target
MEK; TGF-beta/Smad
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles.html
Purity
99.84
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
N#CC1=C(NC2=CC=CC=C2C(F)(F)F)SNC1=O
Molecular Formula
C11H6F3N3OS
Molecular Weight
285.25
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog